General Pharmacology of DWP 301, a New Combined Drug for Gastroduodenal Diseases

위장질환 치료용 의약조성물(DWP 301)의 일반약리작용

  • 임승욱 ((주)대웅제약 중앙연구소) ;
  • 염제호 ((주)대웅제약 중앙연구소) ;
  • 김영만 ((주)대웅제약 중앙연구소) ;
  • 심점순 ((주)대웅제약 중앙연구소) ;
  • 박남준 ((주)대웅제약 중앙연구소) ;
  • 장병수 ((주)대웅제약 중앙연구소) ;
  • 연제덕 ((주)대웅제약 중앙연구소) ;
  • 김병오 ((주)대웅제약 중앙연구소) ;
  • 강진석 ((주)대웅제약 중앙연구소)
  • Published : 1994.12.01

Abstract

The general and some pharmacological actions of DWP 301 were investigated in animals and the following results were obtained. In central nervous system, DWP 301 had no effects on the pentobarbital induced anaesthesia, rotarod test, traction test, analgesic action, anticonvulsant action in mice and body temperature in rat. But DWP 301 showed a little decrease of locomotor activity at a dose of 3,000 mg/kg. From these results, DWP 301 was considered to have little pharmacological effect on the central nervous system. Furthermore, DWP 301 had no influences on the normal blood pressure and heart rate. DWP 301 showed no effect on the isolated guinea pig ileum, trachea, right atrium, and nonpregnant rat uterus. But, in the isolated guinea pig vas deference, DWP 301 had showed inhibitory effect on the contractions produced by norepinephrine. DWP 301 showed rise of gastric juice pH and decrease of urine volume. Also, DWP 301 had no effect on the gastrointestinal motility and blood aggregation. From these results, it is concluded that the general pharmacological effect of DWP 301 are similar to or weaker than M and AGA.

Keywords